XNAS · Healthcare · Medical Instruments & Supplies
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | Q1 2026 | 1.67 | 1.97 | +17.96% | $530.2M | ✅ Beat | +0.02% | -0.07% | — |
| 2026-02-19 | Q4 2025 | 1.54 | 1.91 | +24.03% | $540.7M | ✅ Beat | +0.00% | +0.72% | -16.28% |
| 2025-11-06 |
| Q3 2025 |
| 1.31 |
| 2.03 |
| +54.96% |
| $537.0M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-02-27 | Q4 2024 | 1.48 | 2.11 | +42.57% | $629.8M | ✅ Beat | -2.28% | -5.03% | -7.27% |
| 2024-11-12 | Q3 2024 | 1.25 | 1.59 | +27.20% | $589.1M | ✅ Beat | -1.80% | -4.67% | -6.98% |
| 2024-08-07 | Q2 2024 | 1.00 | 1.56 | +56.00% | $596.5M | ✅ Beat | +24.27% | +21.52% | +33.28% |
| 2024-05-07 | Q1 2024 | 0.82 | 0.96 | +17.07% | $566.7M | ✅ Beat | -1.15% | +3.42% | +6.46% |
| 2024-02-27 | Q4 2023 | 1.19 | 1.57 | +31.93% | $587.9M | ✅ Beat | — | — | — |
Showing last 8 quarters.